Free Trial
OTCMKTS:BFNH

BioForce Nanosciences Q3 2026 Earnings Results & Report

BioForce Nanosciences logo
$6.70 +0.01 (+0.15%)
As of 12:12 PM Eastern

BioForce Nanosciences reported Q3 2026 earnings on November 9, 2026. The company reported EPS of -$0.01.

Earnings Announcement Details

Quarter
Q3 2026
Report Date
Time
After Market Closes

BioForce Nanosciences EPS Results

Actual EPS
-$0.01
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

BioForce Nanosciences Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

BioForce Nanosciences Q3 2026 Earnings FAQ

BioForce Nanosciences (OTCMKTS:BFNH) reported earnings of -$0.01 per share for Q3 2026. The report was announced on Monday, November 9, 2026.

BioForce Nanosciences Earnings Headlines

BioForce Nanosciences (OTCMKTS:BFNH) Stock Falls 1.4% - What's Next?
A free stock pick, from me to you
Elon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.tc pixel
BioForce Nanosciences Delays Annual 10-K Filing
See More BioForce Nanosciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like BioForce Nanosciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BioForce Nanosciences and other key companies, straight to your email.

About BioForce Nanosciences

BioForce Nanosciences (OTCMKTS:BFNH), Inc. developed nanotechnology tools and systems for life-science and biotechnology applications. Its technology was designed to manipulate, deposit and analyze very small quantities of biological materials, supporting research in areas such as proteomics, genomics, diagnostics and drug discovery.

The company’s product portfolio included the Nano eNabler molecular printer, a platform intended to create precise arrays of proteins, DNA and other biomolecules on laboratory substrates. BioForce also developed related consumables, instruments and applications for nanoscale sample handling and bioanalytical research.

BioForce Nanosciences was historically based in Ames, Iowa, and served research institutions, biotechnology companies and pharmaceutical organizations. Publicly available information about the company’s current operations, leadership and geographic activities is limited.

View BioForce Nanosciences Profile